NeuBase Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2023.
  • NeuBase Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$2.81M, a 63.6% increase year-over-year.
  • NeuBase Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$15.3M, a 54.2% increase year-over-year.
  • NeuBase Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$33.3M, a 25.4% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$26.6M, a 55.6% decline from 2020.
  • NeuBase Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$17.1M, a 33.1% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$15.3M -$2.81M +$4.91M +63.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$20.2M -$3.69M +$4.67M +55.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$24.8M -$4.16M +$5.77M +58.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$30.6M -$4.6M +$2.7M +37% Oct 1, 2022 Dec 31, 2022 10-QT 2023-06-05
Q3 2022 -$33.3M -$7.72M -$554K -7.73% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$32.8M -$8.36M +$478K +5.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$33.2M -$9.93M -$4.03M -68.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$29.2M -$7.3M -$2.64M -56.7% Oct 1, 2021 Dec 31, 2021 10-QT 2023-06-05
Q3 2021 -$26.6M -$7.17M -$2.06M -40.4% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-21
Q2 2021 -$24.5M -$8.84M -$5.01M -131% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$19.5M -$5.9M -$1.54M -35.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$17.9M -$4.66M -$879K -23.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q3 2020 -$17.1M -$5.11M +$15M +74.6% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-23
Q2 2020 -$32.1M -$3.82M -$1.86M -95.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$30.2M -$4.36M -$2.41M -124% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$27.8M -$3.78M -$2.31M -157% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$25.5M -$20.1M -$13.8M -216% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-23
Q2 2019 -$11.8M -$1.96M -$794K -68.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$11M -$1.95M +$236K +10.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$11.2M -$1.47M +$2.71M +64.8% Oct 1, 2018 Dec 31, 2018 10-Q 2020-03-26
Q3 2018 -$13.9M -$6.37M -$1.11M -21.2% Jul 1, 2018 Sep 30, 2018 10-K 2019-01-03
Q2 2018 -$12.8M -$1.17M +$2.69M +69.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$15.5M -$2.18M +$5.51M +71.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$21M -$4.18M +$2.79M +40% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$23.8M -$5.26M +$1.55M +22.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-01-03
Q2 2017 -$25.3M -$3.86M +$3.74M +49.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$29.1M -$7.69M -$1.09M -16.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$28M -$6.98M -$3.38M -94.2% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 -$24.6M -$6.81M -$3.35M -96.9% Jul 1, 2016 Sep 30, 2016 10-K 2016-12-22
Q2 2016 -$21.2M -$7.6M -$4.26M -128% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$17M -$6.6M +$210K +3.09% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$17.2M -$3.59M +$613K +14.6% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$17.8M -$3.46M -$382K -12.4% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-22
Q2 2015 -$17.4M -$3.33M -$1.28M -62.2% Apr 1, 2015 Jun 30, 2015 10-K 2016-12-22
Q1 2015 -$16.1M -$6.81M -$4.84M -246% Jan 1, 2015 Mar 31, 2015 10-K 2016-12-22
Q4 2014 -$11.3M -$4.21M -$2.18M -108% Oct 1, 2014 Dec 31, 2014 10-K 2016-12-22
Q3 2014 -$9.12M -$3.08M -$1.27M -70.7% Jul 1, 2014 Sep 30, 2014 10-K 2015-12-14
Q2 2014 -$7.85M -$2.06M -$721K -54% Apr 1, 2014 Jun 30, 2014 10-K 2015-12-14
Q1 2014 -$7.13M -$1.97M -$1.3M -195% Jan 1, 2014 Mar 31, 2014 10-K 2015-12-14
Q4 2013 -$5.83M -$2.02M -$1.21M -148% Oct 1, 2013 Dec 31, 2013 10-K 2015-12-14
Q3 2013 -$4.62M -$1.8M -$555K -44.5% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-22
Q2 2013 -$4.07M -$1.34M -$701K -110% Apr 1, 2013 Jun 30, 2013 10-K 2014-12-22
Q1 2013 -$3.36M -$668K +$239K +26.4% Jan 1, 2013 Mar 31, 2013 10-K 2014-12-22
Q4 2012 -$3.6M -$815K -$318K -63.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-12-22
Q3 2012 -$3.29M -$1.25M -$871K -232% Jul 1, 2012 Sep 30, 2012 10-K 2014-12-22
Q2 2012 -$2.42M -$635K -$333K -111% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$2.08M -$907K -$692K -320% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$1.39M -$497K -$147K -41.9% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 -$1.24M -$376K Jul 1, 2011 Sep 30, 2011 10-K 2013-01-09
Q2 2011 -$302K +$53.1K +15% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 -$216K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q4 2010 -$350K Oct 1, 2010 Dec 31, 2010 10-Q/A 2012-02-14
Q2 2010 -$355K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.